• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估用于表征弹性密封件中亚可见颗粒的颗粒技术。

Evaluation of Particle Techniques for the Characterization of Subvisible Particles From Elastomeric Closure Components.

机构信息

West Pharmaceutical Services, 530 Herman O. West Drive, Exton, Pennsylvania 19341.

KBI Biopharma, 2500 Central Avenue, Colorado 80301.

出版信息

J Pharm Sci. 2020 May;109(5):1725-1735. doi: 10.1016/j.xphs.2020.01.026. Epub 2020 Feb 1.

DOI:10.1016/j.xphs.2020.01.026
PMID:32017902
Abstract

Evaluating a particle profile for parenteral drug products is a well-known challenge due to inevitable variability of results with limited accuracy to actual particle levels present in the product, especially in the subvisible particulate (SbVP) range. It is important to understand the appropriate SbVP counting/characterization technology, methodology capability, and the particle source (intrinsic or extrinsic). Elastomeric closures are prevalent in many types of drug product container closure systems and are a known source of particle contribution. These components need to be considered when establishing a drug product particle profile. In this work, we describe available particle extraction methodology and its applicability in the analysis of elastomeric closure components using multiple detection technologies. Optimum sample preparation and analytical techniques were established to evaluate submicron particle and SbVP loads from elastomeric closure components. In addition, the impact of stopper siliconization and polysorbate 80 interaction on the degree of SbVPs in the final drug product was assessed.

摘要

评估注射用药物产品的颗粒分布是一项众所周知的挑战,因为其结果不可避免地存在变异性,而且对产品中实际颗粒水平的准确性有限,尤其是在亚可见颗粒(SbVP)范围内。了解适当的 SbVP 计数/表征技术、方法能力以及颗粒来源(内在或外在)非常重要。弹性密封件在许多类型的药物产品容器密封系统中很常见,是颗粒贡献的已知来源。在建立药物产品颗粒分布时需要考虑这些组件。在这项工作中,我们描述了现有的颗粒提取方法及其在使用多种检测技术分析弹性密封件组件中的适用性。建立了最佳的样品制备和分析技术,以评估弹性密封件组件中的亚微米颗粒和 SbVP 负载。此外,还评估了硅化瓶塞和聚山梨酯 80 相互作用对最终药物产品中 SbVPs 程度的影响。

相似文献

1
Evaluation of Particle Techniques for the Characterization of Subvisible Particles From Elastomeric Closure Components.评估用于表征弹性密封件中亚可见颗粒的颗粒技术。
J Pharm Sci. 2020 May;109(5):1725-1735. doi: 10.1016/j.xphs.2020.01.026. Epub 2020 Feb 1.
2
Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.生物治疗性预填充注射器中亚可见颗粒的特征:在滴震后硅油和蛋白质亚可见颗粒的形成中,聚山梨酯和蛋白质的作用。
J Pharm Sci. 2020 Jan;109(1):640-645. doi: 10.1016/j.xphs.2019.10.066. Epub 2019 Nov 2.
3
Silicone-oil-based subvisible particles: their detection, interactions, and regulation in prefilled container closure systems for biopharmaceuticals.基于硅油的亚可见颗粒:在生物制药用预填充容器封闭系统中的检测、相互作用和监管。
J Pharm Sci. 2012 Dec;101(12):4569-83. doi: 10.1002/jps.23328. Epub 2012 Sep 28.
4
Non-Destructive Analysis of Subvisible Particles with Mie-Scattering-Based Light Sheet Technology: System Development.基于 Mie 散射的光片技术对亚可见颗粒的无损分析:系统开发。
J Pharm Sci. 2024 Sep;113(9):2817-2825. doi: 10.1016/j.xphs.2024.07.015. Epub 2024 Jul 18.
5
Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods.溶液性质对通过光阻法和数字成像法测量的亚可见颗粒标准品计数和粒径测定的影响。
Eur J Pharm Sci. 2014 Mar 12;53:95-108. doi: 10.1016/j.ejps.2013.12.014. Epub 2013 Dec 23.
6
A Multicompany Assessment of Submicron Particle Levels by NTA and RMM in a Wide Range of Late-Phase Clinical and Commercial Biotechnology-Derived Protein Products.一种利用 NTA 和 RMM 在广泛的后期临床和商业生物技术衍生蛋白产品中评估亚微米颗粒水平的多公司评估。
J Pharm Sci. 2020 Jan;109(1):830-844. doi: 10.1016/j.xphs.2019.10.025. Epub 2019 Oct 21.
7
Contribution of Intravenous Administration Components to Subvisible and Submicron Particles Present in Administered Drug Product.静脉注射给药组件对给予药物产品中可见和亚可见颗粒的贡献。
J Pharm Sci. 2019 Jul;108(7):2406-2414. doi: 10.1016/j.xphs.2019.02.020. Epub 2019 Mar 5.
8
Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.单纯疱疹病毒2型候选疫苗中固有颗粒的表征及热应激诱导颗粒形成的机制
Curr Pharm Biotechnol. 2017 Nov 10;18(8):638-647. doi: 10.2174/1389201018666170914123305.
9
Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products.缩小差距:治疗性蛋白产品中超亚微米粒径颗粒的流式细胞计数和粒径分析
J Pharm Sci. 2017 Nov;106(11):3215-3221. doi: 10.1016/j.xphs.2017.06.007. Epub 2017 Jun 15.
10
Issues and challenges of subvisible and submicron particulate analysis in protein solutions.蛋白质溶液中可见和亚微米颗粒分析的问题和挑战。
AAPS J. 2012 Jun;14(2):236-43. doi: 10.1208/s12248-012-9335-8. Epub 2012 Mar 6.

引用本文的文献

1
Assessment of Tunable Resistive Pulse Sensing (TRPS) Technology for Particle Size Distribution in Vaccine Formulations - A Comparative Study with Dynamic Light Scattering.可调电阻脉冲传感(TRPS)技术评估在疫苗制剂中的粒度分布 - 与动态光散射的比较研究。
Pharm Res. 2024 May;41(5):1021-1029. doi: 10.1007/s11095-024-03698-y. Epub 2024 Apr 22.